DR. ROGER KENNETH CADY, MD
Marriage and Family Therapists at Kansas Expy, Springfield, MO

2010001, Jan 21, 2010

Sep 10, 2009

12/556677

Roger K. Cady - Ozark MO, US
Paul L. Durham - Springfield MO, US

A61K 31/454, C12Q 1/68, G01N 33/53, A61K 31/421, A61K 31/4196, A61K 31/403, A61K 31/4045, C07K 14/00

514323, 435 6, 435 71, 514376, 514383, 514411, 514414, 514415, 530350

A diagnostic test for determining the efficacy of 5HTagonists in a human patient exhibiting symptoms of a cranial facial pain syndrome includes the steps of collecting a sample of saliva from said human patient; and identifying whether calcitonin-gene-related peptide is present in said sample of saliva.

2010021, Aug 26, 2010

May 7, 2010

12/776052

Roger K. Cady - Ozark MO, US
Paul Durham - Springfield MO, US

G01N 33/53, G01R 27/08

435 71, 324692, 436514, 435 22, 436501

A diagnostic test for a head and facial pain disorder in a human patient includes providing test strip containing one or more antibodies corresponding one or more biological markers associated with the disorder or with multiple disorders. A saliva sample is collected from the human patient and applied to the test strip. The test strip is subsequently evaluated for evidence of binding of one or more of the antibodies with any biological markers present in the saliva sample. The progression of the head and facial pain disorder in the patient may be measured by collecting and evaluating additional saliva samples over time and comparing any changes in the amount of binding activity between or among samples.

6066092, May 23, 2000

Nov 3, 1998

9/185310

Roger K. Cady - Ozark MO
Kathleen U. Farmer - Ozark MO

A61B 500

600300

A preemptive prophylaxis migraine method uses the following cognitive tests: Simple Reaction Time; Running Memory Continuous Performance Task; Matching to Sample; Mathematical Processing Task; and interprets the results as a percent of baseline indicator of need for prophylaxis. A preemptive prophylaxis migraine device includes a microprocessor having a memory; the aforementioned cognitive tests loaded into the memory; means for computing the score on a trial of these tests to establish a baseline, for storing the baseline in the memory, for computing the score of a subsequent trial of the tests, and for comparing the same to the stored baseline; and means for indicating a cognitive change.

2008012, May 29, 2008

Sep 27, 2007

11/862252

Roger K. Cady - Ozark MO, US

G01N 27/26, G01N 27/28

205792, 20440301

A biometric testing and monitoring device includes a biosensor with a substrate having an electrical impedance and a coating, at least a first antibody corresponding to at least a first biological marker on said coating, the antibody being operative for binding with the biological marker present in a sample of saliva from a human patient; and a microprocessor in communication with the biosensor and a network. In an alternate embodiment, the device also includes a cognitive testing module in communication with the microprocessor.

5609617, Mar 11, 1997

Feb 21, 1995

8/390965

C. Norman Shealy - Fair Grove MO
Saul Liss - Hawthorne NJ
Caroline M. Myss - Melrose Park IL
Roger K. Cady - Springfield MO

A61N 136

607 68

A method for enhancing serum dehydroepiandrosterone (DHEA) levels in human beings resulting in improved host response to infection and resistance to pathogenic and opportunistic infectious organisms. The serum concentration of DHEA is elevated through the use of topically applied preparations containing the steroid, progesterone, through two different types of electronic stimulators applied to specific acupuncture points on an individual's body, or by combination of the two methods. One or more of the methods may be applicable to the whole.

2007008, Apr 19, 2007

Nov 8, 2006

11/557771

Roger Cady - Ozark MO, US
Donna Gutterman - Research Triangle Park NC, US
Stephen O'Quinn - Research Triangle Park NC, US

A61K 31/60, A61K 31/522, A61K 31/415, A61K 31/405, A61K 31/19, A61K 31/16, A61K 31/192

514165000, 514263310, 514263320, 514406000, 514570000, 514420000, 514471000, 514629000

A method of preventing the headache phase of migraine in a human comprises administration of a 5HTreceptor agonist or administration of an over-the-counter or nonprescription drug to said human exhibiting prodrome symptoms of migraine. Suitably, the method comprises administration of a migraine headache phase-preventing effective amount of the 5HTor over-the-counter or nonprescription drug. There is disclosed a preemptive prophylaxis migraine method using the following cognitive tests: Simple Reaction Time; Running Memory Continuous Performance Task; Matching to Sample; Mathematical Processing Task; and interpreting the results as a percent of baseline indicator of need for prophylaxis.